December 2nd 2020
As the world remains battling the coronavirus pandemic, there are still significant and unmet needs for those fighting chronic conditions and disorders like opioid use disorder (OUD).
October 11th 2020
The PDUFA date for Alkermes' combination therapy is November 15, 2020.
July 4th 2020
October 22nd 2019
The opioid crisis cost the U.S. billions. Find out the impact on the future economy.
Despite the trust between physicians and patients, some physicians believe another prescription drug crisis may arise.
The Impact of Primary Care Appointment Times on Opioid Prescribing
A new study reveals that when physicians are under time constraints it can greatly impact their treatment decisions.
Missing Data Masks Scale of Opioid Epidemic
Study shows a significant portion of overdoses in the U.S. mortality data is missing information on specific drugs involved.
Study to Assess State Policies Governing Opioid Use and Pregnancy
Information gleaned will be crucial to providers, insurers, and policy makers.
Blue Cross NC Invests in Addiction Treatment Provider
Up to 15 clinics are set to open nationwide in the next year.
The Link Between Opioid Overdose and Household Prescriptions
Individuals without their own prescriptions may be at risk for overdose if they have access to family members’ drugs, according to a new study
New Report is Tackling Workplace Opioid Abuse
The first step to addressing opioid abuse for employers is to identify potential misuse and addiction.
Has the Pendulum Swung Too Far on Restricting Pain Management?
Chronic pain patients on opioid therapy have limited access to primary care providers, which could lead to negative outcomes
The Impact of Preoperative Opioid Use on Patient Outcomes
A new study has revealing findings about the effects of front-end opioid prescribing for knee, hip, and shoulder joint replacement patients.
Drug Diversion Remains Problem, But Who Is to Blame?
A new survey shows that while many healthcare executives recognize drug diversion as a problem, few admit to it happening in their organization.
First Opioid Trial Against Manufacturer by State Under Way in Oklahoma
In the first of many similar cases, the trial of Oklahoma versus Johnson & Johnson could frame who is to blame for the opioid epidemic.
Opinion: Pharmacy and Medical Data: A Vital Resource in Fighting the Opioid Epidemic
Access to broad snapshot of the patient’s pharmacy and medical data can help spot and address drug misuse.
FDA Did Not Step Up to Halt Risky Fentanyl Prescribing
A new study suggests that the FDA and manufacturers did not act when evidence emerged that potentially lethal fentanyl products were being inappropriately prescribed to patients.
Top 10 States with the Highest Drug Use Problems
WalletHub released a study on Highest Drug Use by State to highlight the areas that stand to be most affected. Here are the top 10.
Four Facts Healthcare Execs Should Know About the Drug Crisis
Here are certain facts that every executive responsible for managing populations at risk for prescription drug misuse should know as they make policy decisions affecting patient care and financial management.
What Every Healthcare Executive Must Remember as 2019 Approaches
While we all want to predict the future so we can avoid obstacles, we cannot allow our desire for clarity to become an obstacle itself.
What’s Missing from Hospital Opioid Stewardship Programs
A survey from Vizient identifies top strategies for the treatment of pain.
Six Ways to Effectively Manage Pain During an Opioid Epidemic
Healthcare stakeholders can impact a patient’s health by leveraging available capabilities and resources to help achieve better health outcomes and address this opioid epidemic.
Independence Blue Cross President: How We Curb the Opioid Epidemic
Philadelphia has the purest and cheapest heroin in the country and a long history of multigenerational heroin addicted families. Here’s what Independence Blue Cross is doing about it.
Four Ways Health Execs Can Help Patients Recover from Addiction
Here are 4 key ways healthcare executives can leverage community resources to strengthen the availability of tools that support recovery from opioid addiction.
Hospital CEO Keeps Pediatric Care Local
This month’s featured exec is Deborah Feldman, president and CEO of Dayton Children’s Hospital. Here, she sheds light on how the future of healthcare is shaping up, and how value-based care, the ACA, and pediatric pain management fit in.
Group Recommends Employers Discuss Opioids with Health Plans, PBMs
Recommendations focus on ways to prevent opioid misuse and reduce risk of addiction.
How Opioid Use Disorder Meds Affect Opioid Death Rates
A first-of-its kind study examined the association between using medication to treat OUD and mortality in patients who had a nonfatal opioid overdose.
How Technology Can Help Track Opioid Prescriptions, Slow Opioid Crisis
Congress recently began hearings on proposals to combat opioid abuse. Our policy analyst weighs in.
Rural America Not Meeting Residents’ Mental Health Needs
Ball State University study: A severe shortage of mental health professionals in rural areas, as well as opioid and drug problems, is a major concern.
Finally, Good News Regarding Opioid Use
A new report is making some healthcare executives a bit more optimistic about efforts to curb the opioid epidemic. Find out why.
2 Clarke Drive Cranbury, NJ 08512